US · Healthcare · Medical Devices
EPS came in at -0.04 against a street estimate of -0.05 — a beat of 20.0%.
Analysts rate Butterfly Network Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $8.06.
| Fund | Stake |
|---|---|
| BlackRock Inc | 5.99% |
| Glenview Capital Management LLC | 5.38% |
| Fosun International Ltd | 4.02% |
| Hood River Capital Management LLC | 3.24% |
| Vanguard Capital Management, LLC | 3.08% |
| State Street Corp | 2.08% |
| ARK Investment Management LLC | 1.96% |
| Geode Capital Management, LLC | 1.81% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 | 2026-07-30 |
| Results announced · Q3 2026 | 2026-07-30 |
| Shareholder vote results · Q2 2026 | 2026-06-22 |
| Board / officer change · Q2 2026 | 2026-05-08 |
| Quarterly report · Q1 2026 | 2026-04-30 |
| Results announced · Q2 2026 | 2026-04-30 |
| Proxy statement · Q2 2026 | 2026-04-27 |
| Annual report FY2025 | 2026-02-27 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Butterfly Network Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.